These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30182776)

  • 1. Grouping of nanomaterials to read-across hazard endpoints: a review.
    Lamon L; Aschberger K; Asturiol D; Richarz A; Worth A
    Nanotoxicology; 2019 Feb; 13(1):100-118. PubMed ID: 30182776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grouping of nanomaterials to read-across hazard endpoints: from data collection to assessment of the grouping hypothesis by application of chemoinformatic techniques.
    Lamon L; Asturiol D; Richarz A; Joossens E; Graepel R; Aschberger K; Worth A
    Part Fibre Toxicol; 2018 Sep; 15(1):37. PubMed ID: 30249272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a systematic method to assess similarity between nanomaterials for human hazard evaluation purposes - lessons learnt.
    Park MV; Catalán J; Ferraz N; Cabellos J; Vanhauten R; Vázquez-Campos S; Janer G
    Nanotoxicology; 2018 Sep; 12(7):652-676. PubMed ID: 29732939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into possibilities for grouping and read-across for nanomaterials in EU chemicals legislation.
    Mech A; Rasmussen K; Jantunen P; Aicher L; Alessandrelli M; Bernauer U; Bleeker EAJ; Bouillard J; Di Prospero Fanghella P; Draisci R; Dusinska M; Encheva G; Flament G; Haase A; Handzhiyski Y; Herzberg F; Huwyler J; Jacobsen NR; Jeliazkov V; Jeliazkova N; Nymark P; Grafström R; Oomen AG; Polci ML; Riebeling C; Sandström J; Shivachev B; Stateva S; Tanasescu S; Tsekovska R; Wallin H; Wilks MF; Zellmer S; Apostolova MD
    Nanotoxicology; 2019 Feb; 13(1):119-141. PubMed ID: 30182766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grouping and Read-Across Approaches for Risk Assessment of Nanomaterials.
    Oomen AG; Bleeker EA; Bos PM; van Broekhuizen F; Gottardo S; Groenewold M; Hristozov D; Hund-Rinke K; Irfan MA; Marcomini A; Peijnenburg WJ; Rasmussen K; Jiménez AS; Scott-Fordsmand JJ; van Tongeren M; Wiench K; Wohlleben W; Landsiedel R
    Int J Environ Res Public Health; 2015 Oct; 12(10):13415-34. PubMed ID: 26516872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manufactured nanomaterials: categorization and approaches to hazard assessment.
    Gebel T; Foth H; Damm G; Freyberger A; Kramer PJ; Lilienblum W; Röhl C; Schupp T; Weiss C; Wollin KM; Hengstler JG
    Arch Toxicol; 2014 Dec; 88(12):2191-211. PubMed ID: 25326817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multilaboratory evaluation of 15 bioassays for (eco)toxicity screening and hazard ranking of engineered nanomaterials: FP7 project NANOVALID.
    Bondarenko OM; Heinlaan M; Sihtmäe M; Ivask A; Kurvet I; Joonas E; Jemec A; Mannerström M; Heinonen T; Rekulapelly R; Singh S; Zou J; Pyykkö I; Drobne D; Kahru A
    Nanotoxicology; 2016 Nov; 10(9):1229-42. PubMed ID: 27259032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxicity screening and cytokine profiling of nineteen nanomaterials enables hazard ranking and grouping based on inflammogenic potential.
    Bhattacharya K; Kiliç G; Costa PM; Fadeel B
    Nanotoxicology; 2017 Aug; 11(6):809-826. PubMed ID: 28816564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research strategies for safety evaluation of nanomaterials, part II: toxicological and safety evaluation of nanomaterials, current challenges and data needs.
    Holsapple MP; Farland WH; Landry TD; Monteiro-Riviere NA; Carter JM; Walker NJ; Thomas KV
    Toxicol Sci; 2005 Nov; 88(1):12-7. PubMed ID: 16120754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping).
    Arts JH; Hadi M; Irfan MA; Keene AM; Kreiling R; Lyon D; Maier M; Michel K; Petry T; Sauer UG; Warheit D; Wiench K; Wohlleben W; Landsiedel R
    Regul Toxicol Pharmacol; 2015 Mar; 71(2 Suppl):S1-27. PubMed ID: 25818068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sameness: The regulatory crux with nanomaterial identity and grouping schemes for hazard assessment.
    Walser T; Studer C
    Regul Toxicol Pharmacol; 2015 Aug; 72(3):569-71. PubMed ID: 26049104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of physicochemical properties of nanomaterials and their immediate environments in high-throughput screening of nanomaterial biological activity.
    Wang A; Marinakos SM; Badireddy AR; Powers CM; Houck KA
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):430-48. PubMed ID: 23661551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case studies putting the decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping) into practice.
    Arts JH; Irfan MA; Keene AM; Kreiling R; Lyon D; Maier M; Michel K; Neubauer N; Petry T; Sauer UG; Warheit D; Wiench K; Wohlleben W; Landsiedel R
    Regul Toxicol Pharmacol; 2016 Apr; 76():234-61. PubMed ID: 26687418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics and machine learning to support nanomaterial grouping.
    Bahl A; Halappanavar S; Wohlleben W; Nymark P; Kohonen P; Wallin H; Vogel U; Haase A
    Nanotoxicology; 2024 Jul; ():1-28. PubMed ID: 38949108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of control banding tools for nanomaterials.
    Sánchez Jiménez A; Varet J; Poland C; Fern GJ; Hankin SM; van Tongeren M
    J Occup Environ Hyg; 2016 Dec; 13(12):936-949. PubMed ID: 27314531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grouping MWCNTs based on their similar potential to cause pulmonary hazard after inhalation: a case-study.
    Murphy F; Jacobsen NR; Di Ianni E; Johnston H; Braakhuis H; Peijnenburg W; Oomen A; Fernandes T; Stone V
    Part Fibre Toxicol; 2022 Jul; 19(1):50. PubMed ID: 35854357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The applicability of chemical alternatives assessment for engineered nanomaterials.
    Hjorth R; Hansen SF; Jacobs M; Tickner J; Ellenbecker M; Baun A
    Integr Environ Assess Manag; 2017 Jan; 13(1):177-187. PubMed ID: 26887668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomaterial translocation--the biokinetics, tissue accumulation, toxicity and fate of materials in secondary organs--a review.
    Kermanizadeh A; Balharry D; Wallin H; Loft S; Møller P
    Crit Rev Toxicol; 2015; 45(10):837-72. PubMed ID: 26140391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concern-driven integrated approaches for the grouping, testing and assessment of nanomaterials.
    Landsiedel R
    Environ Pollut; 2016 Nov; 218():1376-1380. PubMed ID: 26586635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical appraisal of existing concepts for the grouping of nanomaterials.
    Arts JH; Hadi M; Keene AM; Kreiling R; Lyon D; Maier M; Michel K; Petry T; Sauer UG; Warheit D; Wiench K; Landsiedel R
    Regul Toxicol Pharmacol; 2014 Nov; 70(2):492-506. PubMed ID: 25108058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.